Market Overview The pregabalin market is epileptic as adjunctive therapy supports seizure control in partial-onset epilepsy, offering rapid onset, linear pharmacokinetics, and minimal drug interactions that simplify combination therapy. The Pregabalin Market recognizes epilepsy as established though smaller indication. Current Market Landscape Adjunctive therapy for partial seizures. Pregabalin...